Brainstorm Total Current Liabilities vs Total Assets Analysis

BCLI Stock  USD 2.23  0.16  7.73%   
Brainstorm Cell financial indicator trend analysis is way more than just evaluating Brainstorm Cell Ther prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Brainstorm Cell Ther is a good investment. Please check the relationship between Brainstorm Cell Total Current Liabilities and its Total Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Total Current Liabilities vs Total Assets

Total Current Liabilities vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Brainstorm Cell Ther Total Current Liabilities account and Total Assets. At this time, the significance of the direction appears to have weak relationship.
The correlation between Brainstorm Cell's Total Current Liabilities and Total Assets is 0.36. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Total Assets in the same time period over historical financial statements of Brainstorm Cell Therapeutics, assuming nothing else is changed. The correlation between historical values of Brainstorm Cell's Total Current Liabilities and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Brainstorm Cell Therapeutics are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Current Liabilities i.e., Brainstorm Cell's Total Current Liabilities and Total Assets go up and down completely randomly.

Correlation Coefficient

0.36
Relationship DirectionPositive 
Relationship StrengthVery Weak

Total Current Liabilities

Total Current Liabilities is an item on Brainstorm Cell balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Brainstorm Cell Therapeutics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Assets

Total assets refers to the total amount of Brainstorm Cell assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Brainstorm Cell Ther books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Brainstorm Cell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Brainstorm Cell Ther current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The Brainstorm Cell's current Selling General Administrative is estimated to increase to about 11.2 M, while Issuance Of Capital Stock is projected to decrease to under 13.7 M.

Brainstorm Cell fundamental ratios Correlations

0.89-0.180.360.9-0.92-0.280.940.770.990.350.290.610.550.40.50.990.89-0.280.480.760.55-0.240.15-0.06-0.11
0.89-0.310.40.76-0.79-0.270.840.810.850.290.210.560.420.360.550.850.85-0.460.510.810.49-0.160.23-0.11-0.04
-0.18-0.310.18-0.340.19-0.69-0.170.03-0.220.650.72-0.020.050.660.16-0.23-0.19-0.260.310.030.46-0.330.160.0-0.15
0.360.40.18-0.07-0.23-0.560.330.670.230.510.490.430.440.520.980.270.4-0.290.570.660.56-0.630.960.030.43
0.90.76-0.34-0.07-0.860.030.830.470.950.110.010.460.390.120.080.940.76-0.180.270.470.260.08-0.27-0.04-0.25
-0.92-0.790.19-0.23-0.860.18-0.99-0.69-0.92-0.17-0.18-0.46-0.48-0.31-0.38-0.92-0.880.14-0.24-0.68-0.530.21-0.010.090.21
-0.28-0.27-0.69-0.560.030.18-0.27-0.66-0.17-0.82-0.99-0.39-0.35-0.99-0.63-0.17-0.230.35-0.61-0.66-0.880.69-0.470.040.26
0.940.84-0.170.330.83-0.99-0.270.790.920.210.260.490.480.390.490.910.89-0.160.30.790.62-0.30.11-0.12-0.21
0.770.810.030.670.47-0.69-0.660.790.670.450.610.590.50.710.810.670.7-0.230.510.990.85-0.630.5-0.07-0.19
0.990.85-0.220.230.95-0.92-0.170.920.670.280.190.540.480.310.371.00.87-0.250.420.660.46-0.120.02-0.08-0.16
0.350.290.650.510.11-0.17-0.820.210.450.280.840.450.420.830.520.30.3-0.680.850.430.6-0.330.410.130.03
0.290.210.720.490.01-0.18-0.990.260.610.190.840.390.370.990.560.190.2-0.320.60.60.86-0.670.4-0.01-0.3
0.610.56-0.020.430.46-0.46-0.390.490.590.540.450.390.90.430.480.580.49-0.30.530.510.4-0.40.280.50.14
0.550.420.050.440.39-0.48-0.350.480.50.480.420.370.90.390.470.520.38-0.240.480.420.41-0.410.30.550.19
0.40.360.660.520.12-0.31-0.990.390.710.310.830.990.430.390.610.310.34-0.370.620.710.91-0.660.4-0.04-0.32
0.50.550.160.980.08-0.38-0.630.490.810.370.520.560.480.470.610.40.51-0.290.580.80.69-0.680.9-0.040.29
0.990.85-0.230.270.94-0.92-0.170.910.671.00.30.190.580.520.310.40.87-0.280.440.660.45-0.140.07-0.05-0.09
0.890.85-0.190.40.76-0.88-0.230.890.70.870.30.20.490.380.340.510.87-0.370.380.70.46-0.160.19-0.08-0.04
-0.28-0.46-0.26-0.29-0.180.140.35-0.16-0.23-0.25-0.68-0.32-0.3-0.24-0.37-0.29-0.28-0.37-0.74-0.21-0.17-0.21-0.23-0.12-0.27
0.480.510.310.570.27-0.24-0.610.30.510.420.850.60.530.480.620.580.440.38-0.740.480.44-0.180.460.150.18
0.760.810.030.660.47-0.68-0.660.790.990.660.430.60.510.420.710.80.660.7-0.210.480.87-0.650.5-0.21-0.2
0.550.490.460.560.26-0.53-0.880.620.850.460.60.860.40.410.910.690.450.46-0.170.440.87-0.760.42-0.18-0.37
-0.24-0.16-0.33-0.630.080.210.69-0.3-0.63-0.12-0.33-0.67-0.4-0.41-0.66-0.68-0.14-0.16-0.21-0.18-0.65-0.76-0.610.20.02
0.150.230.160.96-0.27-0.01-0.470.110.50.020.410.40.280.30.40.90.070.19-0.230.460.50.42-0.61-0.070.57
-0.06-0.110.00.03-0.040.090.04-0.12-0.07-0.080.13-0.010.50.55-0.04-0.04-0.05-0.08-0.120.15-0.21-0.180.2-0.070.08
-0.11-0.04-0.150.43-0.250.210.26-0.21-0.19-0.160.03-0.30.140.19-0.320.29-0.09-0.04-0.270.18-0.2-0.370.020.570.08
Click cells to compare fundamentals

Brainstorm Cell Account Relationship Matchups

Brainstorm Cell fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.5M51.3M29.3M8.5M4.2M4.0M
Other Current Liab1M506K1.2M1.1M2.8M3.0M
Total Current Liabilities17.7M11.2M6.3M8.8M7.8M4.2M
Total Stockholder Equity(12.2M)35.5M19.3M(3.0M)(4.9M)(4.6M)
Net Debt1.8M(30.6M)(13.8M)3.3M(628K)(659.4K)
Retained Earnings(117.3M)(149.1M)(173.5M)(197.8M)(215.0M)(204.3M)
Cash536K37.8M18.9M772K1.3M1.2M
Non Current Assets Total3.2M8.0M6.0M5.3M2.3M1.6M
Cash And Short Term Investments569K41.9M22.1M3.0M1.3M1.2M
Common Stock Shares Outstanding21.9M29.8M36.2M36.5M43.1M45.2M
Liabilities And Stockholders Equity6.5M51.3M29.3M8.5M4.2M4.0M
Non Current Liabilities Total1.1M4.6M3.6M2.7M1.3M1.3M
Other Current Assets1.2M432K984K1.1M548K306.8K
Other Stockholder Equity105.0M184.5M192.9M194.8M210.1M220.6M
Total Liab18.8M15.8M9.9M11.5M9.1M4.9M
Total Current Assets3.4M43.2M23.3M3.1M1.9M1.8M
Property Plant And Equipment Net3.1M8.0M6.0M5.3M2.1M1.6M
Property Plant And Equipment Gross3.1M8.0M8.2M5.3M6.1M6.4M
Accounts Payable15.4M5.4M3.7M6.2M5.0M2.7M
Non Currrent Assets Other32.0K26.0K27.0K23.0K207K137.3K
Net Receivables2.4M304K86K91K51K48.5K
Other Assets32K26K27K23K26.5K25.1K
Property Plant Equipment3.1M8.0M6.0M5.3M6.1M6.4M
Net Tangible Assets(12.2M)35.5M19.3M(3.0M)(3.5M)(3.3M)
Retained Earnings Total Equity(94.0M)(117.3M)(149.1M)(173.5M)(156.2M)(148.4M)
Short Term Investments33K4.1M3.2M2.2M2.5M4.9M
Capital Surpluse94.6M105.0M184.7M193.0M221.9M233.0M
Net Invested Capital(12.2M)35.5M19.3M(3.0M)(3.5M)(3.3M)
Net Working Capital(14.3M)32.0M17.0M(5.7M)(6.5M)(6.2M)

Currently Active Assets on Macroaxis

When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainstorm Cell Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.45)
Return On Assets
(1.78)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.